MY129356A - Electrospun pharmaceutical compositions - Google Patents

Electrospun pharmaceutical compositions

Info

Publication number
MY129356A
MY129356A MYPI20010355A MYPI20010355A MY129356A MY 129356 A MY129356 A MY 129356A MY PI20010355 A MYPI20010355 A MY PI20010355A MY PI20010355 A MYPI20010355 A MY PI20010355A MY 129356 A MY129356 A MY 129356A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical compositions
electrospun
electrospun pharmaceutical
pharmaceutically acceptable
therapy
Prior art date
Application number
MYPI20010355A
Inventor
Francis Ignatious
John M Baldoni
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MY129356A publication Critical patent/MY129356A/en

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Textile Engineering (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Mechanical Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

THE PRESENT INVENTION IS DIRECTED TO AN ELECTROSPUN PHARMACEUTICAL COMPOSITION COMPRISING A PHARMACEUTICALLY ACCEPTABLE ACTIVE AGENT, AND A PHARMACEUTICALLY ACCEPTABLE POLYMERIC CARRIER FOR USE IN THERAPY.(FIG 1)
MYPI20010355A 2000-01-28 2001-01-26 Electrospun pharmaceutical compositions MY129356A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28

Publications (1)

Publication Number Publication Date
MY129356A true MY129356A (en) 2007-03-30

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20010355A MY129356A (en) 2000-01-28 2001-01-26 Electrospun pharmaceutical compositions

Country Status (18)

Country Link
EP (1) EP1251829A4 (en)
JP (1) JP2003521493A (en)
KR (1) KR100806412B1 (en)
CN (1) CN1223340C (en)
AR (1) AR028204A1 (en)
AU (1) AU772830B2 (en)
BR (1) BR0107869A (en)
CA (1) CA2396640A1 (en)
HU (1) HUP0301130A3 (en)
IL (1) IL150642A0 (en)
MX (1) MXPA02007298A (en)
MY (1) MY129356A (en)
NO (1) NO20023338L (en)
NZ (1) NZ519992A (en)
PL (1) PL356924A1 (en)
TW (1) TWI289061B (en)
WO (1) WO2001054667A1 (en)
ZA (1) ZA200205989B (en)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
BR0114839A (en) * 2000-10-18 2006-11-07 Univ Virginia Commonwealth composition, and method of releasing a substance or electroprocessed material at a desired location
JP4485124B2 (en) * 2000-11-17 2010-06-16 ヴァージニア コモンウェルス ユニバーシティ インテレクチュアル プロパティー ファンデーション Electroprocessed collagen
JP2010163435A (en) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation Electroprocessed collagen
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
US20020084178A1 (en) 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
JP2004530054A (en) * 2001-03-20 2004-09-30 ナイキャスト リミテッド Method and apparatus for improving the mechanical properties of nonwoven materials
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
ATE395044T1 (en) 2002-02-01 2008-05-15 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHIC DISPERSIONS OF ACTIVE INGREDIENTS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS
KR100549140B1 (en) 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 Ultra-fine nanofiber web manufacturing method by electro-blowing
EP1490538B1 (en) 2002-04-04 2011-11-16 The University of Akron, Akron Ohio Non-woven fiber assemblies
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
WO2003087443A1 (en) * 2002-04-11 2003-10-23 Secant Medical, Inc. Covering process using electrospinning of very small fibers
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
WO2004062697A2 (en) 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
JP2007501218A (en) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance
BRPI0418330A (en) 2003-12-31 2007-05-02 Pfizer Prod Inc solid compositions of low solubility drugs and poloxamers
JP4526851B2 (en) * 2004-03-31 2010-08-18 明彦 谷岡 Polysaccharide nanoscale fibers and compacts
WO2006006746A1 (en) * 2004-07-09 2006-01-19 Hak-Yong Kim Polymer particles, and a method for manufacturing the same
CN100577720C (en) * 2005-03-21 2010-01-06 中国科学院化学研究所 Biodegradable and absorbable polymer nanofiber membrane material and its preparation method and use
JP2006299459A (en) * 2005-04-20 2006-11-02 National Institute For Materials Science Method for producing biodegradable polymer non-woven tube
CN1300393C (en) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 Preparation method of ultrafine fiber medical agent type emulsion electro spinning fiber
DE112006001898B4 (en) * 2005-07-21 2013-05-08 National Institute For Materials Science Device for inhaling medicines
JP4787585B2 (en) * 2005-09-29 2011-10-05 帝人株式会社 Manufacturing method of fiber structure by electrostatic spinning method
CN100556399C (en) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 A kind of intestine target medicinal controlled release fiber and preparation method thereof
US8367112B2 (en) 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (en) * 2006-09-04 2008-04-24 주식회사 아모메디 Biodegradable food packaging material consisting of starch-containing nanofiber nonwoven fabric and its manufacturing method
US8765170B2 (en) 2008-01-30 2014-07-01 The Procter & Gamble Company Personal care composition in the form of an article
CA2719637C (en) 2008-03-27 2014-10-28 Agigma, Inc. Methods and compositions for the delivery of agents
ES2640162T3 (en) 2008-04-16 2017-11-02 The Procter & Gamble Company Composition for non-foaming personal hygiene in the form of an article
EP2328567A2 (en) 2008-08-08 2011-06-08 Basf Se Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof
EP2323635A2 (en) * 2008-08-08 2011-05-25 Basf Se Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
CN101721751B (en) * 2008-10-10 2013-01-02 张阳德 Human tissue engineering support loaded with controlled-release cell growth factor and provided with hollow silicon dioxide ball with kernel and preparation method and applications thereof
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (en) * 2009-02-13 2011-09-16 김근형 New Drug Delivery System Using Electrospinning of Biodegradable Polymers
CN101559242B (en) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 A kind of can simultaneously as the nano artificial cerebral dura mater and preparation method thereof of drug controlled release system
WO2011029777A1 (en) 2009-09-11 2011-03-17 Basf Se Methods for producing coated polymer fibers
WO2011072009A1 (en) 2009-12-08 2011-06-16 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres
US9173826B2 (en) 2010-02-16 2015-11-03 The Procter & Gamble Company Porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
CN101816627B (en) * 2010-04-16 2012-03-07 浙江大学 Synergistic treatment type multi-material sustained-release eye drop and preparation method
RU2541275C2 (en) * 2010-07-02 2015-02-10 Дзе Проктер Энд Гэмбл Компани Filaments, containing non-aromatised active agent, non-woven cloths and methods of obtaining thereof
CN102971126B (en) 2010-07-02 2016-03-23 宝洁公司 The method of film is prepared by non-woven webs
WO2012003365A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
CN103025930B (en) 2010-07-02 2014-11-12 宝洁公司 Method for delivering an active agent
BR112013000101A2 (en) 2010-07-02 2016-05-17 Procter & Gamble filaments comprising active agent nonwoven webs and methods of manufacture thereof
MX386348B (en) * 2010-07-02 2025-03-18 Procter & Gamble ARTICLE WITH A SOLUBLE FIBROUS WEFT STRUCTURE THAT INCLUDES ACTIVE AGENTS.
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
MX345025B (en) 2010-07-02 2017-01-12 Procter & Gamble Detergent product.
CN101915797B (en) * 2010-07-27 2011-09-28 北京师范大学 Method for preparing electrostatic spinning immobilized laccase electrode
WO2012070028A1 (en) 2010-11-26 2012-05-31 University Of The Witwatersrand, Johannesburg A pharmaceutical dosage form
WO2012084427A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions comprising structured non-aqueous liquid phase
WO2012084441A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions in the form of fibres
CZ201124A3 (en) 2011-01-17 2012-06-13 Elmarco S.R.O. Carrier for oromucosal, especially sublingual application of physiologically active compounds
CN102251317B (en) * 2011-05-18 2013-01-16 东华大学 Preparation method of electrospun fibers with controllable drug release
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
CN102631715A (en) * 2012-05-04 2012-08-15 江南大学 Preparation method of anti-coagulation nano fiber membrane
CN102670483B (en) * 2012-05-09 2014-04-02 上海交通大学 Electrostatic spinning fiber membrane preparation for treating hyperlipidemia and preparation method thereof
CN102697727B (en) * 2012-06-12 2014-01-08 东华大学 Method for preparing self-assembly ketoprofen liposome by electrostatic spinning technology
KR101454360B1 (en) 2012-08-31 2014-10-24 서울대학교산학협력단 A gelatin nanofibrous web containing Phaeodactylum triconutum extracts and wound dressing using the same
MX370280B (en) 2012-10-12 2019-12-09 Procter & Gamble Personal care composition in the form of a dissolvable article.
WO2014131376A1 (en) * 2013-02-26 2014-09-04 Elmarco S.R.O. Electrospun nanofibers comprising pharmaceutically active agents
US9775917B2 (en) 2013-03-12 2017-10-03 Active Fibres Limited Nanofibre and bioactive compositions and related methods
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
US20150315350A1 (en) 2014-04-22 2015-11-05 The Procter & Gamble Company Compositions in the Form of Dissolvable Solid Structures
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
NZ746573A (en) * 2014-06-10 2023-07-28 Afyx Therapeutics As Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
CN105362269A (en) * 2014-09-01 2016-03-02 天津药物研究院 Saccharose containing roflumilast tablets and preparation method thereof
HK1249411A1 (en) * 2015-03-31 2018-11-02 奥梭瑞贝斯株式会社 Method for manufacturing drug-containing biodegradable fiber material by electrospinning
CN108025477A (en) * 2015-07-07 2018-05-11 新加坡保健服务集团 Polymeric articles and its preparation
CN105327357B (en) * 2015-10-14 2019-01-11 北京科技大学 A kind of drug-loading system of hyaluronic acid and preparation method thereof of catechol modification
RU2701513C2 (en) * 2015-11-19 2019-09-27 Афикс Терапьютикс А/С Pharmaceutical composition containing electrohydrodynamically produced fibers, composition having improved retention time at site of use
US12194158B2 (en) 2016-01-27 2025-01-14 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment
CN105727358B (en) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 Drug-loaded biological high-molecular composite nanometer tunica fibrosa and preparation method thereof
CN105663025A (en) * 2016-02-29 2016-06-15 浙江工业大学 Drug-containing microfilament and preparation method thereof
IL268185B2 (en) 2017-01-23 2024-01-01 Afyx Therapeutics As A method for preparing fibers produced by electrospinning with a high content of biological adhesive
KR102592782B1 (en) 2017-01-23 2023-10-20 에이에프와이엑스 테라퓨틱스 에스에이 Method for manufacturing two-layer products based on electrospun fibers
MX380853B (en) 2017-01-27 2025-03-12 Procter & Gamble Compositions in the form of dissolvable solid structures
JP6882519B2 (en) 2017-01-27 2021-06-02 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Composition in the form of a soluble solid structure comprising effervescent agglomerated particles
WO2018213003A1 (en) 2017-05-16 2018-11-22 The Procter & Gamble Company Conditioning hair care compositions in the form of dissolvable solid structures
CN107447366A (en) * 2017-08-03 2017-12-08 东华大学 A kind of sensitive medicament-carried sustained release nano fiber films of pH and its preparation method and application
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US20190233785A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US11142730B2 (en) 2018-01-26 2021-10-12 The Procter & Gamble Company Water-soluble articles and related processes
CN111556891B (en) 2018-01-26 2021-11-05 宝洁公司 Water-soluble unit-dose preparations containing enzymes
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
JP7121944B2 (en) * 2018-05-07 2022-08-19 国立大学法人信州大学 Nanofiber and its manufacturing method
JP1639110S (en) 2018-07-16 2019-08-13
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US12234431B2 (en) 2018-10-03 2025-02-25 The Procter & Gamble Company Water-soluble unit dose articles comprising water-soluble fibrous structures and particles
WO2020159860A1 (en) 2019-01-28 2020-08-06 The Procter & Gamble Company Recycleable, renewable, or biodegradable package
JP7513623B2 (en) 2019-03-19 2024-07-09 ザ プロクター アンド ギャンブル カンパニー Method for reducing malodors on fabrics
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
CN114206307B (en) 2019-06-28 2024-08-23 宝洁公司 Soluble solid fiber products containing anionic surfactants
EP3993757A1 (en) 2019-07-03 2022-05-11 The Procter & Gamble Company Fibrous structures containing cationic surfactants and soluble acids
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
CN114555483B (en) 2019-10-14 2024-04-26 宝洁公司 Biodegradable and/or home compostable sachets containing solid products
EP4061320B1 (en) 2019-11-20 2024-07-03 The Procter & Gamble Company Porous dissolvable solid structure
JP7617104B2 (en) 2019-12-01 2025-01-17 ザ プロクター アンド ギャンブル カンパニー Hair conditioner composition having a preservative system containing sodium benzoate and glycol and/or glyceryl esters
IT202000002833A1 (en) * 2020-02-13 2021-08-13 Bakel S R L ELECTRO-THREADING PROCESS
US20230081596A1 (en) * 2020-02-13 2023-03-16 Bakel S.R.L. Method of electrospinning natural polymers
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
MX2023001042A (en) 2020-07-31 2023-02-16 Procter & Gamble Water-soluble fibrous pouch containing prills for hair care.
US11633336B2 (en) 2020-08-11 2023-04-25 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
WO2022036352A1 (en) 2020-08-11 2022-02-17 The Procter & Gamble Company Clean rinse hair conditioner compositions containing brassicyl valinate esylate
US11633338B2 (en) 2020-08-11 2023-04-25 The Procter & Gamble Company Moisturizing hair conditioner compositions containing brassicyl valinate esylate
JP7605842B2 (en) 2020-08-19 2024-12-24 ザ プロクター アンド ギャンブル カンパニー FLEXIBLE POROUS DISSOLVEABLE SOLID SHEET ARTICLE CONTAINING DIRECT-LOAD MICROCAPSULES AND METHODS FOR MAKING SAME - Patent application
EP4255384A1 (en) 2020-12-01 2023-10-11 The Procter & Gamble Company Aqueous hair conditioner compositions containing solubilized anti-dandruff actives
USD1045064S1 (en) 2020-12-17 2024-10-01 The Procter & Gamble Company Single-dose dissolvable personal care unit
CN113041230B (en) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 Capsule shell of soft capsule and soft capsule prepared from capsule shell
WO2023034763A1 (en) 2021-08-30 2023-03-09 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
KR102653460B1 (en) * 2021-09-01 2024-03-29 한남대학교 산학협력단 A method for manufacturing starch nanofiber comprising collagen and lecithin with controlled degradability
MX2024005474A (en) 2021-12-17 2024-05-22 Procter & Gamble Dissolvable solid fibrous shampoo articles containing salts.
JPWO2023145886A1 (en) * 2022-01-31 2023-08-03
MX2024010903A (en) 2022-03-10 2024-09-17 Procter & Gamble Dissolvable solid structure having first and second layers.
CN114808184A (en) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 Long-acting mosquito-repelling electrostatic spinning fiber and preparation method and application thereof
CN115887422B (en) * 2022-12-31 2024-06-07 兰州交通大学 A lappaconitine knee joint analgesic sustained-release patch and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
AU772830B2 (en) 2004-05-06
EP1251829A1 (en) 2002-10-30
CN1223340C (en) 2005-10-19
JP2003521493A (en) 2003-07-15
HUP0301130A3 (en) 2006-07-28
PL356924A1 (en) 2004-07-12
CA2396640A1 (en) 2001-08-02
IL150642A0 (en) 2003-02-12
CN1396823A (en) 2003-02-12
AU3113401A (en) 2001-08-07
NO20023338L (en) 2002-09-03
ZA200205989B (en) 2003-02-03
KR20020082212A (en) 2002-10-30
WO2001054667A1 (en) 2001-08-02
MXPA02007298A (en) 2002-12-09
TWI289061B (en) 2007-11-01
NO20023338D0 (en) 2002-07-11
AR028204A1 (en) 2003-04-30
BR0107869A (en) 2002-11-05
EP1251829A4 (en) 2009-05-06
KR100806412B1 (en) 2008-02-21
NZ519992A (en) 2004-04-30
HUP0301130A2 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
MY129356A (en) Electrospun pharmaceutical compositions
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
AU7315301A (en) Compounds and compositions for delivering active agents
PL347671A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (en) Compounds and compositions for delivering active agents.
TW355683B (en) Composition containing micronized nebivolol
IL140710A0 (en) Pulmonary delivery of active agents
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
IL141762A0 (en) New oral formulations
GB2365772A (en) Factor
EP1478406A4 (en) COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC SUBSTANCES AND ANALOGS, AND METHODS OF MAKING AND USING THE SAME
BG106030A (en) Pharmaceutical composition
BG66093B1 (en) Controlled release compositions comprising nimesulide
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
DK0703786T3 (en) Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS
MY119403A (en) Novel compounds with analgesic effect.
YU38802A (en) Novel composition and use
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
DE60023107D1 (en) PREPARATIONS WITH IMPROVED CONTROLLED RELEASE
AU2855399A (en) Vascularization inhibitors
SE9802208D0 (en) Novel compounds
ID28510A (en) NEW ORAL FORMULATION FOR AGONISTS OR 5-HT4 ANTAGONISTS
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
TW324662B (en) Benzamide-containing pharmaceutical composition
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser